Merit Financial Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Other funds holding VNDA
ACM
Merit Financial Group's VNDA Position: Q3 2026 in Review
Merit Financial Group sold out of Vanda Pharmaceuticals (VNDA) in Q3 2026, closing a stake of 26,167 shares — an estimated $160K sold.
Merit Financial Group first reported a position in VNDA in Q1 2026 and held it in 2 quarters. The position peaked at $160K in Q2 2026. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.
- Merit Financial Group reported no remaining Vanda Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Merit Financial Group sold 26,167 Vanda Pharmaceuticals shares in Q3 2026, an estimated $160K.
- Merit Financial Group first reported a position in Vanda Pharmaceuticals in Q1 2026 and held it in 2 quarters.
- Merit Financial Group's Vanda Pharmaceuticals position peaked at $160K in Q2 2026.
- 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.
Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.